ERBB2 and breast cancer: Dicer positivity was also associated with expression of basal-like biomarker EGFR and, in the analysis of breast cancer subtypes, luminal A subtype showed a significantly lower proportion of Dicer positive patients than basal-like and HER2 overexpressing subtypes.